Bright Minds Biosciences
DRUG
9 hedge funds and large institutions have $310K invested in Bright Minds Biosciences in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.01% more ownership
Funds ownership: 0.67% → 0.68% (+0.01%)
36% less funds holding
Funds holding: 14 → 9 (-5)
39% less capital invested
Capital invested by funds: $509K → $310K (-$199K)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$38.3K |
| 2 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$29.3K |
| 3 |
SG
StoneX Group
New York
|
+$10.1K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$267 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$24K |
| 2 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$14K |
| 3 |
Two Sigma Investments
New York
|
-$14K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$13K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $233K | +$29.3K | +5,917 | +10% |
|
|
VF
2
Virtu Financial
New York
| $29K | +$38.3K | +7,743 | New |
|
|
QFA
3
Quattro Financial Advisors
The Woodlands,
Texas
| $15.7K | – | – | – |
|
|
CCA
4
Checchi Capital Advisers
Beverly Hills,
California
| $10.5K | – | – | – |
|
5
BlackRock
New York
| $8.73K | – | – | – |
|
|
SG
6
StoneX Group
New York
| $7.54K | +$10.1K | +2,039 | New |
|
7
UBS Group
Zurich,
Switzerland
| $3.85K | -$9.53K | -1,925 | -65% |
|
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$267 | +54 | +17% |
|
|
APC
9
Aspire Private Capital
Cornelius,
North Carolina
| $370 | – | – | – |
|
|
10
Jane Street
New York
| – | -$24K | -3,865 | Closed |
|
|
JMPWA
11
JP Morgan Private Wealth Advisors
San Francisco,
California
| – | -$14K | -2,266 | Closed |
|
|
12
Two Sigma Investments
New York
| – | -$14K | -2,214 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$13K | -2,131 | Closed |
|
|
TSS
14
Two Sigma Securities
New York
| – | -$13K | -2,041 | Closed |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| – | -$1K | -126 | Closed |
|
DRUG Hedge Fund Activity: Q4 2022 in Review
9 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Bright Minds Biosciences (DRUG) for Q4 2022, worth a combined $310K — down 39% from $509K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of DRUG and 2 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $38.3K. The largest seller was Jane Street, exiting entirely with an estimated $24K sold.
- 9 institutional investors held Bright Minds Biosciences (DRUG) as of Q4 2022, down from 14 in Q3 2022.
- Funds reported $310K of Bright Minds Biosciences stock for Q4 2022, down 39% quarter-over-quarter.
- 2 funds opened new Bright Minds Biosciences positions in Q4 2022 and 7 closed out, a net change of -5 holders.
- The largest Bright Minds Biosciences buyer in Q4 2022 was Virtu Financial, an estimated $38.3K added.
- The largest Bright Minds Biosciences seller in Q4 2022 was Jane Street, an estimated $24K sold.
Based on aggregated 13F filings for Q4 2022.